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Figure 2. 4 weeks post injury. Safranin-O stain of a) 057 and b) MRL with the
respective Sca-1 IHC on the right.
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identify at what speciﬁc point the healing processes diverge between
the two mice strains.
Methods: Two groups of MRL/MpJ and C57BL/6 male mice (5 weeks of
age; n¼ 6 per time point) were used in the study. A custommade depth
controlled needle (26 gauge) was used to introduce a full thickness
cartilage defect into the femoral groove of the left knee. At 4 and 6
weeks post-surgery, the respective groups were euthanized and the
legs were dissected out and ﬁxed in 10% NBF. Using a 9.4 T magnet and
a quadrature coil, samples underwent ex vivo magnetic resonance
imaging using a RARE sequence (Repetition time ¼ 2000 ms; Echo time
¼ 7.6 ms; FOV ¼1.92; Matrix ¼ 256). After imaging, samples were
decalciﬁed using 10% EDTA, embedded in parafﬁn, and sectioned at 7
um thickness. Sections were then stained with Safranin-O and immu-
nohistochemistry (IHC) was performed using the anti-mouse Ly-6A/E
(also known as Stem Cell Antigen- 1; Sca-1).
Results: MRI scans at 4 weeks showed higher signal intensity at the
cartilage compared to those scanned at 6 weeks (Fig1). There were no
observable differences between strains at each time point. Safranin-O
staining of the C57 sections at the 4 weeks, showed lower proteoglycan
content than the MRL at the same time point. Defects were observable
in C57mice at all time points, but were not observed inMRLmice (Fig2).
However, tissues within the MRL defect were not identical with the
surrounding tissues, in speciﬁc regards to proteoglycan content, matrix
structure, and chondrocyte orientation. Also of interest, it was observed
that Sca-1 positive cells were enriched within the C57 defect, but were
not found within the MRL defect (Fig2).
Conclusion: In this study, we sought to characterize the early stages of
endogenous cartilage repair that occurs in MRL/MpJ mice using both
a non-invasive imaging technique (MRI) and tradition histological
methods. Interestingly, MRI scans revealed that at 4 weeks post injury,
there were no observable differences between C57 and MRL mice,
though the Safranin-O stains did show increased cellularity in MRL
samples at the defect compared to C57. Furthermore, the scarcity of Sca-
1+ cells in MRL samples was surprising as the Safranin-o stains had
revealed the superior healing and increased cellularity of the defect
compared to the C57’s. A possible explanation could be that the
recruitment of Sca-1 cells in the MRL's occurs much earlier than the
time points used in this study. This would explain the lack of Sca-1 cells
as well as the increased cellularity and structural organization at the
defects of the MRL's compared to the C57’s. Future efforts will be
focused on earlier time points than what was used in the present study.Figure 1. Imaging of a) C57 and b) MRL legs 4 weeks post injury as well as the c) C57
and d) MRL legs 6 weeks post injury.212
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A. Purpose: The aim of this study was to compare the effect of adipose
mesenchymal stem cells (aMSC) (Dog Stem) and Plasma rich in
growth factors (PRGF) (PRGF-Endoret) in the treatment of osteoar-
thritis disease (OA) in dogs.
B. Methods: The study was performed in 50 dogs with elbow, knee or
hip degenerative ostheoartritis (documented by X-Rays and clinical
ﬁndings).
The inclusion criteria was the following, healthy animals weighting
more than 20 kg, with presence of OA in one of these joints.
Animals were randomly assigned to one of these two study groups:
 PRGF: one intraarticular injection (2cc) of autologous PRGF obtained
by Anitua's method. Citrate tubes centrifugates at 460G during 8
minutes (n¼23).
 aMSC: one intraarticular injection (2cc containing 30 millions of
mesenchymal stem cells) of autologous adipose mesenchymal stem
cells obtained by Stem Cells method. The adipose tissue was obtained
by open byopsy and cultivated in Stem Cells Laboratories (Belgium)
(n¼25).
Dogs were evaluated the day before the tratment was applied (basal)
and one, three and six months after intraarticular inﬁltrations. The
primary outcome variable was OA degree (assesed by the Bioarth
Ostheoarthritis Scale: radiographic ﬁndings (mild, moderate or severe),
owners questionnaire for functional limitation (measurement scale:
0 to 23 points) and animal joint movement (measurement scale: 0 to 7
points). Additional measures included the visual analogic scale (VAS),
performed by the owner and the veterinarian to assess pain relief
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questions about patients response to the treatment and life quality) and
all adverse effects to treatments recorded (Aes).
Results were analyzed by the SPSS 20.0 program. The nonparametric
Kruskal-Wallis and Mann-Whitney tests were used to compare non-
categorical variables and crosstabs with contingency coefﬁcient to
evaluate the categorical ones.
C. Results: A total of 42 males and 8 females, with mean age of 7439
(8-135) months and mean weigth of 36,611,9 (20-66,2) kg were
included in the study. No differences were appreciated between groups
in these variables.
Mild OA was present in 3 animals from the PRGF group, 3 and 10
animals of the PRGF and aMSC groups respectively, presented moderate
OA, and 17 animals presented severe OA in both groups. OA degree
radiologically evaluated did not vary within groups, and there was no
improvement in time. However, in the rest of variables (functional
limitation, Joint movement, Joint ﬂexion and extension degree, owner’s
and veterinarians VAS, Joint movement range, muscular atrophy and
patient’s life quality) a clear improvement has been seen since the ﬁrst
month of study in both groups, maintaining up to six months, although
the aMSC group obtained better results at 6 months than the PRGF
group in Joint movement (p¼0,022), ﬂexion degree (p¼0,0034),
extension degree (p¼0,02), owners VAS (p¼0,044), veterinarians VAS
(p¼0,00) and range of movement (p¼0,003). There were no adverse
effects present during the study.
D. Conclusions: OA is one of the most common causes of lameness in
dogs. In this study both PRGF and aMSc treatments have demonstrated
to improve functional limitation, joint movement and pain feeling even
without radiological improvement and with absence of adverse effects.
Both AMSC and PRGF therapy are new means of treatment and create
big hopes to overcome cartilage regeneration, maintaining or
improving joint function and structure.Figure 1. Representative images showing toluidine blue staining in osteochondral
defect.
Figure 2. Histological scoring for (A) Regeneration (B) Degeneration, Red line indicates
highest score possible.213
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Purpose: Despite the fact that mesenchymal stem cells (MSC) offer
clinical potential for osteoarthritis applications, retaining sufﬁcient
numbers of functional MSC at the site of injury for optimal repair still
continues to be a major challenge. One method of overcoming this
limitation is to create an artiﬁcial extracellular matrix or scaffold to hold
the cells in place. Previous research suggests that biomaterials pos-
sessing an elastic modulus between 2-50MPa are suitable for functional
cartilage repair. To this end, the main aim of this study was to examine
the effect of scaffold mechanical properties on cartilage repair in
a rabbit model in vivo.
Methods: Two three-dimensional (3D) scaffold structures fabricated
from different biomaterials were selected; a 55/45 wt% polyethylene
oxide terephthalate/polybutylene terephthalate (PEOT/PBT) scaffold
created by 3D ﬁber deposition with a compressive modulus of 3.6 MPa
and a bilayered PGA/PLGA+CaS composite construct (Truﬁt) with
a compressive modulus of 50 MPa. Using scanning electron microscopy,
the 3D architecture of the scaffolds was visualized and the porosities
measured using volume displacement. Upon characterization of rabbit
MSC morphology, growth kinetics and tri-lineage differentiation
potential, the optimal cell seeding density and attachment conditions
were evaluated. Cartilage repair was examined in a 3x3x3 mm osteo-
chondral defect in male White New Zealand rabbits in accordance with
ethical guidelines and approval, with 3 groups, empty defect (n¼3),
empty scaffold (n¼6) and MSC seeded scaffold (n¼6). After 6 weeks,
tissue repair was assessed using toluidine blue staining to evaluate
tissue morphology and a modiﬁed ICRS scoring system using 3-blinded
reviewers to grade cartilage repair.
Results: The 3D architecture of the scaffolds was comparable with
structures previously used for cartilage repair, with porosities of 76%
measured for the PEOT/PBT scaffold and a porosity gradient from 63% to
97% observed for the bilayered Truﬁt construct. Rabbit MSC were
shown to have a ﬁbroblastic morphology and were capable of osteo-
genic, adipogenic and chondrogenic differentiation. Optimal cell
attachment was observed for 1 million cells/scaffold in combinationwith 50mg/ml ﬁbronectin. There was evidence of repair in the empty
defect, however, although not signiﬁcant, cartilage regeneration was
improved and degenerative changes were reduced in the presence of
the scaffolds (Fig 1 and 2). In terms of scoring, no statistical difference
was observed for both scaffolds, in terms of thickness of repair tissue or
integrationwith native tissue. Seeding the PEOT/PBT scaffolds withMSC
appears to produce lower scores for degenerative changes in the repair
tissue and adjacent tissue when compared to the empty, contralateral
control with no cells (Fig 2). In contrast, seeding the Truﬁt scaffold
with MSC does not appear to improve degenerative affects. Moreover,
there are bone cysts visible in the subchondral bone.
Conclusions: In summary, two scaffolds with mechanical properties at
both ends of the materials property spectrumwere analyzed. Although,
both scaffolds revealed interesting, albeit different results, neither
construct produced an optimal result. Thereby, suggesting that cartilage
repair is a multifactorial problem, which is not modulated by
mechanical properties alone.
